Search research articles
Contact Us
Filters
Showing results (501-510 of 553) with videos related to
Page
of 56
Sort By:
Journal of the American Heart Association
|
September 11, 2025
CHOSEN: A Randomized Controlled Feasibility Trial
Craig J Smith, Andrew Brand, Zoe Hoare, et al.
Journal of Lipid Research
|
May 14, 2022
Direct anabolic metabolism of three-carbon propionate to a six-carbon metabolite occurs in vivo across tissues and species
Mary T Doan, Michael D Neinast, Erika L Varner, et al.
Vaccine
|
October 11, 2005
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects
Guy de Bruyn, Mauricio Vargas-Cortez, Terri Warren, et al.
Investigational New Drugs
|
November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
John H Strickler, Shannon McCall, Andrew B Nixon, et al.
Vaccine
|
December 15, 2015
Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine
Innocent N Mbawuike, Robert L Atmar, Shital M Patel, et al.
Science Signaling
|
April 5, 2022
The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17
Daniele Chaves-Moreira, Marilyn A Mitchell, Cristina Arruza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2025
A histochemical approach to activity-based copper sensing reveals cuproplasia-dependent vulnerabilities in cancer
Marco S Messina, Laura Torrente, Aidan T Pezacki, et al.
The Oncologist
|
March 15, 2013
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas
Hope E Uronis, Johanna C Bendell, Ivy Altomare, et al.
Vaccine
|
December 3, 2014
Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations
Sharon E Frey, David I Bernstein, Rebecca C Brady, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 11, 2023
IGF2BP1/IMP1 Deletion Enhances a Facultative Stem Cell State via Regulation of MAP1LC3B
Louis R Parham, Patrick A Williams, Kay Katada, et al.
Page
of 56
Search research articles
Search
Showing results (501-510 of 553) with videos related to
Sort By:
Page
of 56
Journal of the American Heart Association
|
September 11, 2025
CHOSEN: A Randomized Controlled Feasibility Trial
Craig J Smith, Andrew Brand, Zoe Hoare, et al.
Journal of Lipid Research
|
May 14, 2022
Direct anabolic metabolism of three-carbon propionate to a six-carbon metabolite occurs in vivo across tissues and species
Mary T Doan, Michael D Neinast, Erika L Varner, et al.
Vaccine
|
October 11, 2005
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects
Guy de Bruyn, Mauricio Vargas-Cortez, Terri Warren, et al.
Investigational New Drugs
|
November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
John H Strickler, Shannon McCall, Andrew B Nixon, et al.
Vaccine
|
December 15, 2015
Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine
Innocent N Mbawuike, Robert L Atmar, Shital M Patel, et al.
Science Signaling
|
April 5, 2022
The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17
Daniele Chaves-Moreira, Marilyn A Mitchell, Cristina Arruza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2025
A histochemical approach to activity-based copper sensing reveals cuproplasia-dependent vulnerabilities in cancer
Marco S Messina, Laura Torrente, Aidan T Pezacki, et al.
The Oncologist
|
March 15, 2013
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas
Hope E Uronis, Johanna C Bendell, Ivy Altomare, et al.
Vaccine
|
December 3, 2014
Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations
Sharon E Frey, David I Bernstein, Rebecca C Brady, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 11, 2023
IGF2BP1/IMP1 Deletion Enhances a Facultative Stem Cell State via Regulation of MAP1LC3B
Louis R Parham, Patrick A Williams, Kay Katada, et al.
Page
of 56